@xconomy.com 9 months ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com 10 months ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com 10 months ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com 1 year ago
Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D